Transcenta Holding Limited 創勝集團醫藥有限公司

Pay for financial year ended 2023-12-31

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Bao, Jun (Impact Therapeutics) 包駿 INED 200 -10 190
2 Chen, Helen Wei 陳瑋 INED 72 72
3 Qian, Xueming 錢雪明 CEO 1,680 1,129 216 236 2,301 5,562
4 Srinivasan, Kumar INED 200 26 226
5 Tang, Jiasong 唐稼松 INED 200 19 219
6 Weng, Xiaolu 翁曉路 FD 3,009 350 113 4,848 8,320
7 Zhang, Zhihua (1982) 張志華 INED 200 19 219
8 Zhao, Jonathan Yining 趙奕寧 NED, Ch 700 621 110 26 8,135 9,592
Total 3,252 4,759 676 375 15,338 24,400

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 3,252 4,759 676 375 15,338 24,400 Report
Total 3,252 4,759 676 375 15,338 24,400

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top